Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diseases
CAP, ASCO reduce confusion by reaffirming HER2 testing guidelines
The organizations reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.
June 8, 2023
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
Metagenomics study finds antibiotic resistance genes are widespread among bacteria
Bacteria everywhere carry previously unknown genes that make them resistant to antibiotics, potentially aggravating the problem of untreatable bacterial infections.
June 6, 2023
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
The device has conducted more than 180 thousand assessments in pharmacies and primary care clinics in Europe; DeepX is poised to enter the U.S. market.
June 6, 2023
Dante Genomics introduces rare disease health package that leverages telemedicine, sequencing
The package includes telemedicine consultations with specialists who may not be available where a patient is located.
June 6, 2023
Low rates of genetic testing ‘a missed opportunity’ to reduce cancer burden
The probability of a patient undergoing genetic testing increased over the course of the study, although male breast was the only indication that had a more than 50% likelihood of being tested at any time.
June 5, 2023
Blood test detects neurometabolic disease to simplify, accelerate diagnosis
A study compared a blood test METAglut1, which quantifies GLUT1 on the surface of red blood cells, to glycorrhachia measured via lumbar puncture in a prospective cohort of 428 patients and a retrospective cohort of 67 patients.
June 6, 2023
T2 Biosystems seeking FDA breakthrough device designation for Candida auris test
The Lexington, MA-based maker of a molecular platform and tests for sepsis and other bloodstream infections recently announced plans to add Candida auris detection to its FDA-cleared T2Candida Panel.
June 6, 2023
Grail, University of Oxford announce data from large-scale evaluation of multicancer early detection test
Investigators at the ASCO annual meeting described the performance of Grail’s multicancer early detection methylation-based platform, Galleri, in a symptomatic population of more than 6,000 patients.
June 5, 2023
Invivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detection
Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.
June 2, 2023
Labcorp launches liquid biopsy test for oncology
The test, called Labcorp Plasma Focus, enables treating oncologists to evaluate circulating cell-free DNA released by tumor cells.
June 1, 2023
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
The partnership will combine Nucleai's expertise in extracting and analyzing the quantitative spatial features of pathology images and Adlai Nortye's expertise in drug development and immunotherapy.
May 31, 2023
Page 1 of 258
Next Page
